CABA 10th Annual Conference
Chinese-American BioMedical Association (CABA)
CABA members: FREE; Non-members: $30. On-site membership registration available ($30 annual membership fee due).
Conference Organizing Committee:
Chair Kevin Fang, Ph.D.
Co-Chairs Jian Shao, MBA; Lan Cao, Ph.D.; Bo Ying, Ph.D.
For information about CABA and upcoming events, please check CABA Web site: www.cabaweb.org.
09:00 - 10:00 am Registration / Social Networking
10:00 - 10:05 am Opening Remarks, Kevin Fang, Ph.D., Symposium Chair, President-Elect, CABA
10:05 - 10:15 am Introduction of CABA, Eric Shi, Ph.D., President, CABA
Session I – Novel Therapies for Cancer and Neurological Diseases
SESSION CHAIR: Lan Cao, Ph.D. and Cindy Yang, MBA.
10:15 - 10:50 am Samarth Kulkarni, Ph.D., Chief Business Officer, CRISPR Therapeutics. “CRISPR-based Therapeutics: Making it a Reality in Asian Markets”
10:50 - 11:25 am Ken LéClair, VP, Technical Development and Manufacturing, Editas Medicine. “Development of Cell and Gene-Edited Products”
11:25-12:00 pm Carmen Bozic, M.D. SVP Global Develop, Biogen. “Innovations in Intrathecal Antisense Oligonucleotide Therapy for Neurological Diseases”
LUNCH AND VENDOR SHOW: 12:00 - 1:30 pm (Lunch Provided on Site)
12:45 - 1:05 pm John Yao, Ph.D., Co-founder and CEO, TC Scientific Inc. “A CRO’s View of the Pharma Landscape” hosted by Ellen Fan, MSc
SESSION II – Global Innovation, Investment, and Entrepreneurship
SESSION CHAIR: Jian Shao, MBA
1:30 - 2:05 pm Hui Cai, Ph.D., VP of Corporate Alliances and Head of Communications, WuXi AppTec. “Platform and Ecosystem for R&D Transformation”
2:05 - 2:40 pm James Yang, Ph.D., President and CEO, Abpro-China. “Strategic Partnership for Success in Biologics
2:40 - 3:15 pm Yongzhong Wang, Ph.D., President of Pharmaceuticals and Executive VP of Simcere Pharmaceutical Group. “Innovations across the Border, a Personal Journey”
3:15 - 3:50 pm Lynn Yang, MBA, General Manger, Sequoia Capital “Sequoia China Healthcare Investment Strategy”
3:50 - 4:20 pm COFFEE BREAK AND VENDOR SHOW
SESSION III - Global Pharma Trends, CFDA Regulatory Reform and Scientific Advancement in PD-1 Research
SESSION CHAIRS: Wendy Yang, MBA and Susan Qu, Ph.D., MBA
4:20 - 4:55 pm Kenneth Kaitin, Ph.D., Professor and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine “The Global Landscape for Pharmaceutical R&D: Current Trends - Future Opportunities”
4:55 - 5:30 pm XinYu Weng, Ph.D., MBA, First Secretary of the Embassy of the China to the USA. “Overview of CFDA Drug Regulatory Reform”
5:30 - 6:05 pm Gordon Freeman, Dana-Farber Cancer Institute, Professor, Medicine, Harvard Medical School. "PD-1 Cancer Immunotherapy"
6:05 - 6:10 pm Closing Remarks
6:10 - 8:30 pm 10th Anniversary Evening Celebration
Key Feature: Former Presidents' Documentary Film
6:50 - 7:50 pm Dinner
7:50 - 8:30 pm Performances